Merger Arbitrage Mondays – March 4, 2019
Merger activity decreased last week with two new deals announced and six pending deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool (MAT) that automatically updates itself during market hours.
There were two new deals announced in the Deals in the Works section.
Deal Statistics:
New Deals:
- The acquisition of Clementia Pharmaceuticals (CMTA) by Ipsen for $1.31 billion. Under the terms of the agreement, shareholders of Clementia Pharmaceuticals will receive $25.00 per share in cash upfront plus deferred payments in the form of a contingent value right (CVR) of $6.00 per share upon FDA acceptance of the NDA filing for the late-stage drug palovarotene.
- The acquisition of Multi-Color Corporation (LABL) by an affiliate of Platinum Equity for $2.5 billion or $50.00 per share in cash.
Only plus or premium subscribers can access this post. Subscribe today.
